SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 150.60 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 27.70 |
| Book Value / Share | 2.15 |
| Price / Book | n/a |
| NCAV ($M) | -48.98 |
| NCAV / Share | -3.81 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.61 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.87 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.26 |
| Current Ratio | 1.64 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 75.81 |
| Assets | 152.49 |
| Liabilities | 124.79 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 39.12 |
| Operating Income | -33.15 |
| Net Income | -41.97 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -35.53 |
| Cash from Investing | -0.06 |
| Cash from Financing | 46.08 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| SNNC – Sibannac, Inc. | SNPHF – Santen Pharmaceutical Co., Ltd. |
| SNYNF – Sanofi | SPRB – Spruce Biosciences, Inc. |
| SQZB – SQZ Biotechnologies Company |
Financial data and stock pages provided by
Fintel.io